Matching slides 37,461
Current window 18,931-18,960
Pages 1,249
Rows per page 30

Beat

18,931-18,960 of 37,461

filter-aware
08
The chart illustrates a shift in the economic lifecycle curve of drug development.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a combination of stacked bar charts and a side-by-side bar chart to demonstrate efficiency gains.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
10
Uses a histogram to visualize the distribution of rNPV outcomes across different scenarios, highlighting a 593% increase in the best-case scenario.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
The chart uses a stacked area representation to show the growth of different project types over time, aligned with four distinct operational phases.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
12
The slide uses a timeline-like structure to show drug development stages from Early Discovery to Clinical, with a separate box for DaaS (Drug-as-a-Service) products.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
13
The visual uses a network/wave motif to connect the three pillars of their AI approach.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
14
The diagram uses a circular, iterative flow (flywheel-like) to represent the 'learning process' of the AI architecture.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The slide uses a process-flow visual to represent four distinct technical capabilities.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The slide outlines a proprietary laboratory and software workflow.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
17
The slide uses a process flow to demonstrate the efficacy of a drug testing platform.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
18
Includes Kaplan-Meier survival curves and hazard ratios (HR) from a study published in The Lancet Haematology.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
The heatmap uses hierarchical clustering to group patient samples and drug responses.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
20
The slide uses a process flow diagram showing the transition from Target Product Profile (table) to MPO (code snippet) to Merit (scatter plot).Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
21
The diagram uses a hub-and-spoke style flow to represent the integration of multiple data types and AI models into a unified generative design platform.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
22
The slide is entirely white with a circular vignette effect and a page number '22' in the bottom right corner.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
23
The slide contains only a 3D rendering of a protein molecule against a black background, with the company logo in the bottom left corner.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
24
The chart shows a Pareto-like frontier of compounds, with specific points highlighted as 'selected by active learning' that are not necessarily on the immediate performance frontier, demonstrating the 'counterintuitive' claim.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
25
The visual is a node-link diagram representing complex data relationships, likely protein-ligand interactions or chemical space mapping.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
26
Includes a biological pathway diagram and a honeycomb diagram representing cancer indications.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
27
The slide uses a three-column structure to define the target product profile (TPP) for a drug candidate.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
28
The table uses a traffic-light color coding system (green/yellow/red) to indicate performance against criteria.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
29
The table uses a color-coded system (green, yellow, red) to indicate performance relative to candidate criteria.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
30
The charts show dose-dependent tumor regression in mouse models.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
31
The slide uses a series of small-multiple line charts to demonstrate dose-response curves across different time points (24h, 48h, 72h).Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
32
The slide uses a small multiples approach to show individual patient responses across three different experiments (EXP403, EXP617, EXP665) and three time points (24h, 48h, 72h).Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
33
Exscientia | IPO Presentation Deck | 60 slidesExscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
34
This is a standard corporate footer/contact slide often found at the end of a pitch deck.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
35
The visualization appears to be a node-link diagram representing a network or cluster structure.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
36
Uses a visual flow to represent the drug discovery process bottlenecks.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
37
The network graph likely represents drug discovery pathways or viral transmission modeling.Exscientia | IPO Presentation Deck | 60 slides · Exscientia
Pitch deck Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit